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The study was carried on diabetic foot patients to deduce clinical attributes, the
occurrence of the range of aerobic microbial flora and to assess their comparative in vitro
susceptibility to the customarily used antimicrobials. We also studied the potential risk
factors involved in the development of non-healing ulcers. A total of 87 organisms were
isolated from 70 specimens, including Escherichia coli (19.5%) among the Gram-negative
and Staphylococcus aureus (18.4%) among the Gram-positive as the predominant
aerobes explored. Pseudomonas aeruginosa and E. coli were predominant isolates of
non-healing ulcers. The antimicrobial sensitivity pattern revealed that vancomycin (100%)
and amikacin (90.4%) exhibited highest sensitivity to Gram-positive cocci, while all strains
of P. aeruginosa were sensitive toward imipenem (100%). The prevalent uncontrolled
glycemic status, altered lipid spectra, the existence of neuropathy, and peripheral
vascular disease, suggested predisposition toward the development of non-healing
lesions. The study has underlined the need for continuous surveillance of bacteria
and their antimicrobial sensitivity blueprints to provide the basis for empirical therapy
and to minimize the risk of complications. Further, stringent clinical evaluation, and
medical history will help in revealing the risk of developing non-healing status in diabetic
foot ulcers.
Keywords: Type 2 diabetes, Diabetic foot infection, Multi-drug resistant organisms, Non-healing ulcers,
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INTRODUCTION
Diabetes mellitus being the global epidemic of 21st century, ultimately leads to end-organ damage
due to hyperglycemia, imposing a major health burden. Diabetes-associated foot ulcers, followed
by infection causes substantial morbidity and dreaded complications like systemic toxicity,
gangrene, and lower extremity loss. The cumulative lifetime incidence for the development of
foot ulcers in diabetes is as high as 25% (Noor et al., 2015). More than 85% of lower extremity
amputations in patients with diabetes are preceded by foot ulcers (Pecoraro et al., 1990). Diabetic
peripheral neuropathy and peripheral arterial disease are the key etiologic agents in foot ulceration.
These may act together with other factors such as biomechanical, immunological imbalances,
microvascular disease, foot deformities, hindered joint mobility, and increased susceptibility to
infection thereby representing diabetic foot ulcers (DFUs) as a major social, medical and economic
problem of developing countries (Eneroth et al., 1999). Infection is diagnosed on the presence
of ≥2 classical signs of inflammation (erythema, edema, and purulence). Spanning the spectrum
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from simple, superficial cellulitis, microbial flora can lead
to chronic osteomyelitis, and dreaded systemic toxicity
along with gangrenous limbs resulting in lower extremity
amputation (Lipsky et al., 2004). Often in association with lack
of sensation, stiffened arteries, compromised host immune
response, and recurrence of ulcers especially harbored by
multidrug-resistant organisms places diabetic foot patients at
higher risk of non-healing ulcers. Earlier studies have shown
that most diabetic foot infections are polymicrobial with a
predominance of Gram-positive cocci especially S. aureus,
and Streptococci (Sapico et al., 1984; Jones et al., 1985).
However, recent studies indicate the dominance of Gram-
negative pathogens in the monomicrobial state, particularly
members of family Enterobacteriace and Pseudomonas (Tiwari
et al., 2011; Turhan et al., 2013). The prolonged course of
antimicrobials for uninfected lesion or healed wounds, long
hospital stay, and surgical measures may predispose patients to
colonization and infection with drug-resistant pathogens and
associated adverse outcomes. Multidrug-resistant organisms like
methicillin-resistant Staphylococcus aureus (MRSA), metallo-
beta-lactamases (MBL), extended-spectrum beta-lactamases
(ESBL) producers, and ampicillin-resistant beta-lactamases
(AmpC) producers further complicate the aura making lower
extremity loss more common (Dang et al., 2003; Tascini et al.,
2006; Kandemir et al., 2007; Richard et al., 2008). Proper wound
management requires early analysis of infection and prompt
initiation of appropriate antimicrobial therapy.
For infected ulcers, a post-debridement specimen from tissue
should be obtained and processed for detection of causative
pathogens (Zubair et al., 2010). Antibiotic susceptibility testing
is a prerequisite for the management of infections which can help
to make better therapeutic choices.
The present study was designed to characterize common
bacterial microbes in diabetic foot wounds, explore the drug
sensitivity pattern of isolates and analysis of changing etiology
of DFUs in North Indian population. Since poor healing status
is a major cause of lower extremity amputations in diabetics, the
study is also aimed to uncover the potential risk factors associated
with the development of non-healing ulcers in diabetics.
RESEARCH DESIGNS AND METHODS
Study Designs
A prospective hospital-based study was conducted in Jawaharlal
Nehru Medical College, Aligarh Muslim University, Aligarh,
India during the period from July 2014 to March 2016. Ninety
type 2 diabetic patients with foot ulcers were admitted to
endocrinology ward. Seventy patients with infected DFUs were
enrolled in the study. All the subjects gave informed consent, and
clearance was obtained from the Bio-Ethical Committee (BEC),
Faculty of Medicine, J.N. Medical College, Aligarh Muslim
University, Aligarh.
Clinical Examination
A well-structured questionnaire was developed for a detailed
history and physical examination. Subjects were clinically
assessed for age, sex, body mass index (BMI), lipid profile,
duration of diabetes, glycemic status, liver, and renal
functionality. Patients were also clinically evaluated for presence
of other comorbidities such as retinopathy (fundoscopy),
nephropathy (creatinine >1.5 mg% or presence of micro- or
macro-albuminuria), neuropathy (absence of perception of the
Semmes—Weinstein monofilament at 2 of 10 standard planter
sites on either foot), peripheral vascular disease (ischemic
symptoms and intermittent claudication of rest pain, with or
without absence of pedal pulses or posterior tibial pulses) and
hypertension (previous medication of anti-hypertensive drug
or a BP ≥ 140/90mmHg). Clinical assessment of infection in
the wound was made with the occurence of classic signs of
inflammation (redness, swelling, tenderness, warmth, or pain) or
purulent secretions or additional minor signs of non-purulent
secretions (friable or discolored granulation tissue, undermining
of wound edges, foul odor). Duration and size of ulcer were
calculated by multiplying longest and widest diameters and
expressed in centimeter square. Ulcers were graded using
Wagner classification system, grade I (superficial ulcer or ulcer
of subcutaneous tissue), grade II (ulcers extended into tendon,
bone, or capsule), grade III (deep ulcer with osteomyelitis, or
abscess), and grade IV (gangrene of toes). Subjects with grade
0 (uninfected lesions/ intact skin/ healed ulcers) were debarred
from the study. Amputation was defined as the complete loss
in the transverse anatomical plane of any part of the lower
limb. Diagnosis of infection involving bone was done by either
using a sterile probe in exposed bone or evidence obtained from
plain radiographs or magnetic resonance imaging (MRI) in the
absence of sinus tract.
Specimen Collection
Pus aspirates or soft tissue samples were collected on the day
of admission after proper cleaning of the diabetic wound with
saline followed by debridement of superficial tissue exudates and
promptly sent to a laboratory and processed for aerobic bacterial
identification as described by Gadepalli et al. (2006).
Venous blood samples were collected after an overnight fast
and centrifuged at 3000 rpm for 5min at 4◦C. Serum or plasma
was immediately separated and stored in aliquots at−80◦C until
further analysis.
Microbiological Analysis
All pus samples were Gram-stained and the bacteria were
isolated by inoculation of specimens on a set of selective and
non-selective media such as blood agar, MacConkey agar, and
nutrient agar (Hi Media, Mumbai, India), and were incubated at
37◦C overnight. Isolated organisms were identified on the basis
of culture characteristics, colony morphology, and biochemical
reactions as per the standard protocols (Collee et al., 1996).
Susceptibility Testing
Antimicrobial susceptibility testing of aerobic isolates was
done by using Mueller-Hinton agar using Kirby-Bauer disk
diffusion method as recommended by Clinical and Laboratory
Standards Institute (2006b). The antibiotic panels for each
group of isolates were selected according to the Clinical
and Laboratory Standards Institute (2006a). Antimicrobials
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used in the study were, cefotaxime (30µg), cefepime
(30µg), imipenem (10µg), cefixime (5µg), cefoperazone
(75µg), cefoperazone/sulbactam (75/10µg), ceftazidime
(30µg), amikacin (30µg), ceftriaxone (30µg), oxacillin
(1µg), piperacillin (100µg), piperacillin/tazobactam
(100/10µg), cefoxitin (30µg), chloramphenicol (30µg),
gentamicin (10µg), levofloxacin (5µg), sparfloxacin (5µg),
streptomycin (10µg), vancomycin (30µg), tobramycin
(10µg), and erythromycin (15µg). Dried disks were stored
in refrigerator. An appropriate dilution of a broth culture was
spread on Mueller-Hinton agar plate using sterile swabs. Plates
were dried at 37◦C for 30min, and antibiotic disks (4 or 5 per
10 cm plate) were applied with sterile forceps. After overnight
incubation at 37◦C, the level of sensitivity was determined by
measuring the zones of inhibition of growth around the disks.
Growth was inhibited around disks containing antimicrobials
to which the bacterium was susceptible but not around those to
which it was resistant.
Clinical Investigations
Plasma/ serum obtained at the day of admission were
processed for estimation of HbA1c by ion- exchange high-
performance liquid chromatography (Bio-Rad D-10, India)
and glucose estimation by colorimetric assays. Serum lipid
analysis (triglycerides, total cholesterol, LDL- cholesterol, HDL-
cholesterol, VLDL-cholesterol, and phospholipids) was done
using commercially available kits (Avantor, U.S.A) according to
manufacturer guidelines (Allain et al., 1974).
Statistical Analysis
Quantitative variables were represented as means ± standard
deviation and categorical data as a percentage (%). Student’s t-test
or chi- square test was used to compare the differences between
the groups. A two-tailed p < 0.05 was considered as statistically
significant. Statistical analyses were carried out using Medcalc
software version 15.11.4.
RESULTS
Demographical Variables
Out of 90 type 2 diabetic patients with DFUs admitted to
endocrinology ward, seventy had infected DFUs. Patients were
grouped depending upon healing and non-healing state of ulcer
following routine examination based on healing signs/symptoms.
Routine clinical examination of ulcers was done up-to 2 months
from the day of admission to evaluate the healing status. Non-
healing lesions were clinically diagnosed on the basis of absence
of epithelialization, angiogenesis, and formation of granulation
tissues. Patients with non-healing wounds were significantly
older than those without it (p < 0.05). HbA1c (p < 0.05), fasting
plasma glucose (p < 0.05), serum triglyceride (p < 0.01), and
low density lipoprotein (p < 0.01) were significantly elevated in
subjects with non-healing ulcers as compared to those without
it. Patients with non- healing infected ulcers had had a higher
prevalence of neuropathy (p < 0.05), peripheral vascular disease
(p < 0.05), and osteomyelitis (p < 0.05) than those with healing
TABLE 1 | Clinical and demographical variables of subjects with healing
and non-healing ulcers.
Characteristics Healing Ulcers Non-healing Ulcers p value
N 27 43
Male (%) 22 (78.5%) 29 (82.5%) NS
Age (yrs) 50.2± 10.8 55.9±11.6 <0.05
Diabetes duration (yrs) 7.6± 5.5 7.4±5.1 NS
BMI (kg/m2) 25.5± 5.2 31.1±3.1 <0.0001
HbA1c (%) 9.1± 2.0 11±3.6 <0.05
FPG (mg/dL) 170± 44.2 200.7±58.6 <0.05
Se. Cr (mg/dL) 1.4± 0.8 1.2±0.5 NS
LIPID PROFILE
TC (mg/dL) 164.2± 22.4 170.2±29.43 NS
TAGs (mg/dL) 148.3± 38.9 183.1±54.8 <0.01
HDL (mg/dL) 47.6± 10.1 39.4±6.6 <0.0001
LDL (mg/dL) 71.6± 11.3 78.0±6.1 <0.01
SIZE OF ULCER (cm2)
<4 cm2 13 (48.1%) 12 (27.9%) <0.05
≥4 cm2 14 (51.8%) 31 (72%)
Ulcer duration (months) 1.2± 0.7 1.7±0.6 <0.05
GRADE OF ULCER
1 1 (3.7%) 2 (4.6%) NS
2 11 (40.7%) 13 (30.2%) NS
3 5 (18.5%) 12 (27.9%) NS
4 8 (29.6%) 16 (37.2%) NS
COMPLICATIONS
Hypertension 11 (39.2%) 18 (45.7%) NS
Retinopathy 20 (71.4%) 29 (77.1%) NS
Neuropathy 16 (39%) 12 (24.3%) <0.05
Nephropathy 24 (85.3%) 32 (95.4%) NS
Peripheral vascular disease 15 (53.5%) 29 (78.3%) <0.05
Osteomyelitis 12 (35.7%) 31 (78.3%) <0.05
Amputation 8 (29.6%) 25 (58.1%) <0.05
Minor 8 (29.6%) 22 (51.1%) NS
Major 0 (0%) 3 (6.9%)
N, number of subjects; BMI, body mass index; HbA1c, glycated hemoglobin; FPG, fasting
plasma glucose; Se. Cr, serum creatinine; TC, total cholesterol; TAG, triglycerides; HDL,
high density lipoprotein; LDL, low density lipoprotein; NS, not significant.
The bold values denote the p value obtained after applying student t-test and Chi-
square statistical analysis when when variables of healing ulcer group were compared
with non-healing ulcer group.
ulcers. Surgical amputations of lower limb were significantly
higher in subjects with non-healing wounds (p < 0.05; Table 1).
Ulcer Characteristics
Among the subjects, the mean duration of infected ulcer was
1.45 ± 0.6 months. Size of ulcer ≥4 cm2 was observed in
45 (64.3%) cases and <4 cm2 in 25 (35.7%) subjects. Surgical
amputation was done in 33 (47.1%) subjects, of which 3
(4.3%) underwent major amputation, and 30 (42.85%) were
subjected to minor amputation. Diabetic foot wounds of non-
healing category were significantly long-standing than healing
wounds (p < 0.05) (Table 1). Of total 70 subjects, 19 (27.1%)
were on antibiotics before admission, 10 (14.3%) were unaware
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of previous medication whereas rest of the subjects did not
received antibiotics. Seventy percent patients had no prior
knowledge of diabetes linked secondary complications and
foot care.
Wound Microbiology
A total of 87 aerobic isolates were identified from 70 ulcer
specimens, averaging 1.2 species per lesion. Fifty-three (75.7%)
had monomicrobial infection, and polymicrobial etiology was
observed in 17 (24.3%) cases. In our study Gram-negative
bacilli were predominant (75.9%) than Gram-positive cocci
(24.1%). In terms of relative abundance, E. coli accounted for
(19.5%), followed by S. aureus (18.4%), P. aeruginosa (17.2%),
Klebsiella species (14.9%), Citrobacter species (12.6%), Proteus
species (11.5%), and Enterococcus faecialis (5.7%).
Subjects with non-healing ulcers during hospital stay had a
predominance of E. coli and P. aeruginosa (13.8% each), followed
by S. aureus (12.6%). Klebsiella species (10.3%), followed by
Citrobacter species (9.2%) were most frequent in healing wounds
(Table 2).
Based on antibiotic susceptibility pattern, 62.5% strains of S.
aureus were found to be resistant to levofloxacin. All strains
of Gram-positive cocci showed sensitivity toward vancomycin
(100%), amikacin (90.5%), and ciprofloxacin (71.4%). MRSA
accounted for 25% of isolated strains of S. aureus and were
resistant to oxacillin (Table 3).
In E. coli, the majority of strains were resistant to
cefoperazone (82.35%), followed by gentamicin, levofloxacin,
and tobramycin (70.6% each). Klebsiella species were
found to be highly resistant to cefixime (84.6%) and
cefoperazone (69.2%). Citrobacter species showed highest
resistance to cefoperazone (81.8%) and ceftriaxone (81.8%),
while resistance to gentamicin and cefepime was 63.6%
each. High level of resistance to amikacin, cefoperazone,
and tobramycin (70% each) was found in Proteus species
(Table 4).
Among the isolates of P. aeruginosa, piperacillin (53.3%),
and piperacillin+ tazobactam (86.6%) showed good activity. All
strains of Pseudomonas aeruginosa were found to be sensitive to
imipenem (Table 5).
TABLE 2 | Distribution of 87 isolates in healing and non-healing diabetic
foot ulcers.
Name of isolates Healing ulcers Non-healing ulcers
n (%) n (%)
Escherichia coli 5 (5.7%) 12 (13.8%)
Staphylococcus aureus 5 (5.7%) 11 (12.6%)
Pseudomonas aeruginosa 3 (3.4%) 12 (13.8%)
Klebsiella species 9 (10.3%) 4 (4.6%)
Citrobacter species 8 (9.2%) 3 (3.4%)
Proteus species 5 (5.7%) 5 (5.7%)
Enterococcus faecialis 2 (2.3%) 3 (3.4%)
n, number of isolates.
DISCUSSION
This study presents a comprehensive clinical and microbiological
contour of infected DFUs in hospitalized patients. Patients with
non-healing ulcers were older and had poor glycemic status than
those with healing wounds. Impaired insulin secretion/action
causes a halt in the uptake of glucose, leading to reduced activity
of fibroblasts, and polymorphonuclear neutrophils causing poor
healing (Rosenberg, 1990).
Subjects with non-healing lesions had a high prevalence of
neuropathy and peripheral vascular disease. Loss of sensation of
peripheral arteries leads to recurrent ulcers with susceptibility
to develop multidrug-resistance isolates due to heavy prior
treatment with antimicrobials, thus causing delayed healing.
Inadequate blood flow caused due to thickening of arteries
of lower extremities creates an ischemic environment and
compromised mobility causing prolonged periods of unrelieved
pressures on the extremities. This results in increased shearing
force applied to the skin and underlying tissues leading to
decrease in oxygen tension and eventual tissue necrosis (Defloor,
1999).
In the present study we observed that out of 87 aerobic
bacteria isolated from 70 pus samples, an average of 1.2
organisms was found. These findings are similar to those reported
by Viswanathan et al. (2002), where cultures yielded an average
of 1.2 isolates per lesion, and were lower than the previous
studies of Zubair et al. (2011), Gadepalli et al. (2006), and
Shahid et al. (2009), with the reported average rate of isolation
between 1.57, 2.3, and 5.8 respectively. The decrease in the
number of isolates (1.2 organisms per lesion) in the present
study in comparison to previously cited reports, could be because
of widespread use of broad-spectrum antibiotics inclusive of
piperacillin/tazobactam by the Primary Health Care physicians
without obtaining proper pus culture before initiating antibiotic.
Unlike Western countries reporting Gram-positive aerobes as
predominant pathogens (Wang et al., 2010; Roberts and Simon,
2012), there has been a changing trend in the microorganisms
causing DFI, with Gram-negative bacteria replacing Gram-
positive bacteria in India (Ramakant et al., 2011; Umadevi et al.,
2011). Interestingly, we have also observed the predominance of
Gram-negative organisms in DFUs in our study and the same
has also been reported by Mehta et al. (2014) and Shankar et al.
(2005). However, previous studies reported the dominance of
Gram-positive aerobes in diabetic foot infection (Mantey et al.,
2000; Fejfarová et al., 2002). The ratio of Gram-negative to
Gram-positive aerobes in our study was 2.9, which is lower than
reported by Gadepalli et al. (2006). The prevalence of this kind
of discrepancy in findings, could be because of geographical
variations, age-sex composition, grading of ulcers and study
settings included in the analysis.
In the present study, E. coli (19.5%), and S. aureus (18.3%)
were the most predominating Gram-negative and Gram-positive
isolates respectively. These findings are similar to those reported
by Kandati et al. (2015) and Girish and Kumar (2011), from
Southern India. Among non- healing ulcers, E. coli and P.
aeruginosa (13.7% each), were most prevalent aerobes. This
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TABLE 3 | Antibiogram of Gram-positive cocci.
Staphylococcus aureus (n = 16) Enterococcus faecialis (n = 5) Total (n = 21)
Antibiotics S (%) R (%) S (%) R (%) S (%) R (%)
Amikacin 14 (87.5%) 2 (12.5%) 5 (100%) 0 (0%) 19 (90.5%) 2 (9.5%)
Erythromycin 10 (62.5%) 6 (37.5%) 4 (80%) 1 (20%) 14 (66.7%) 7 (33.3%)
Ciprofloxacin 11 (68.75%) 5 (31.25%) 4 (80%) 1 (20%) 15 (71.4%) 6 (28.6%)
Gentamicin 10 (62.5%) 6 (37.5%) 4 (80%) 1 (20%) 14 (66.7%) 7 (33.3%)
Levofloxacin 6 (37.5%) 10 (62.5%) 4 (80%) 1 (20%) 10 (47.6%) 11 (52.4%)
Oxacillin 11 (68.75%) 5 (31.25%) 5 (100%) 0 (0%) 16 (76.2%) 5 (23.8%)
Vancomycin 16 (100%) 0 (0%) 5 (100%) 0 (0%) 21 (100%) 0 (0%)
S, sensitive; R, resistant; n, number of isolates.
TABLE 4 | Antibiogram of Enterobacteriace.
Antibiotics Escherichia coli Klebsiella species Citrobacter species Proteus species Total (n = 51)
(n = 17) (n = 13) (n = 11) (n = 10)
S (%) R (%) S (%) R (%) S (%) R (%) S (%) R (%) S (%) R (%)
Amikacin 13 (76.5%) 4 (23.5%) 9 (69.2%) 4 (30.8%) 5 (45.4%) 6 (54.5%) 3 (30%) 7 (70%) 30 (58.8%) 21 (41.2%)
Cefoperazone 3 (17.6%) 14 (82.35%) 4 (30.8%) 9 (69.2%) 2 (18.2%) 9 (81.8%) 3 (30%) 7 (70%) 15 (29.4%) 22 (43.1%)
Cefixime 6 (35.3%) 11 (64.7%) 2 (15.4%) 11 (84.6%) 10 (90.9%) 1 (9.0%) 6 (60%) 4 (40%) 24 (47.0%) 27 (52.9%)
Cefepime 6 (35.3%) 11 (64.7%) 10 (76.9%) 3 (23.1%) 4 (36.4%) 7 (63.6%) 5 (50%) 5 (50%) 25 (49.0%) 26 (51.0%)
Cefetriaxone 6 (35.3%) 11 (64.7%) 10 (76.9%) 3 (23.1%) 2 (18.2%) 9 (81.8%) 4 (40%) 6 (60%) 22 (43.1%) 29 (56.9%)
Gentamicin 5 (29.4%) 12 (70.6%) 6 (46.15%) 7 (53.8%) 4 (36.4%) 7 (63.6%) 4 (40%) 6 (60%) 19 (37.2%) 32 (62.7%)
Levofloxacin 5 (29.4%) 12 (70.6%) 10 (76.9%) 3 (23.1%) 6 (54.5%) 5 (45.4%) 4 (40%) 6 (60%) 25 (49.0%) 26 (51.0%)
Tobramycin 5 (29.4%) 12 (70.6%) 6 (46.15%) 7 (53.8%) 6 (54.5%) 5 (45.4%) 3 (30%) 7 (70%) 20 (39.2%) 30 (58.8%)
Cefeperazone
+ Sulbactam
8 (47.0%) 9 (52.9%) 12 (92.3%) 1 (7.7%) 5 (45.4%) 6 (54.5%) 6 (60%) 4 (40%) 31 (60.8%) 20 (39.2%)
S, sensitive; R, resistant; n, number of isolates.
raises a serious concern for aggressive patterns of Gram-negative
aerobes and their role in the poor healing of diabetic foot wounds.
All strains of S. aureus including MRSA were sensitive to
vancomycin, which is similar to the findings of Reghu et al.
(2016), Kandati et al. (2015), and Mehta et al. (2014), but against
the findings of Girish and Kumar (2011).
Our study has shown that amongst the Enterobacteriace
group, amikacin showed good antimicrobial activity against E.
coli, followed byKlebsiella species,Citrobacter species, and Proteus
species. Amikacin can, therefore, be considered as a better choice
of drug in infection caused by these organisms. Our findings on
the sensitivity of amikacin for Enterobacteriace are in tune with
Girish and Kumar (2011), who reported the highest sensitivity
of amikacin to Citrobacter species (100%), followed by Proteus
species (99%), E. coli (86%) andKlebsiella species (72%). Our study
also indicates that Pseudomonas infection can respond better to
imipenem, which is corroborated by the earlier reports quoting
imipenem, the best sensitive drug to P. aeruginosa (Mantey et al.,
2000; Bansal et al., 2008).
Based on our result and what is documented in literature
so far, it is amply clear that there is no antibiotic which can
cover all isolates, and therefore, a combination of drugs has to be
recommended to overcome the extensive multidrug-resistance.
TABLE 5 | Antibiogram of Pseudomonas aeruginosa.
Pseudomonas aeruginosa (n = 15)
Antibiotics S (%) R (%)
Amikacin 5 (33.3%) 10 (66.7%)
Ceftazidime 4 (26.7%) 11 (73.3%)
Cefepime 4 (26.7%) 11 (73.3%)
Levofloxacin 6 (40.0%) 9 (60.0%)
Sparfloxacin 4 (26.7%) 11 (73.3%)
Tobramycin 5 (33.3%) 10 (66.7%)
Piperacillin 8 (53.3%) 7 (46.7%)
Piperacillin + Tazobactam 12 (80.0%) 3 (20.0%)
Imipenem 15 (100%) 0 (0%)
S, sensitive; R, resistant; n, number of isolates.
The emergence of resistant strains in DFIs is a major hurdle to
our efforts to prevent limb loss as the infection is most common
cause complicating the diabetic foot pathogenesis. Even if the
pathogen is susceptible to one particular antimicrobial, the drug
is unlikely to accomplish therapeutic concentration at the site
of infection due to hindrance caused by deranged host immune
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responses, virulence factors, such as proteases, hemolysins, and
collagenases that cause inflammation and impede wound healing
contribute to the chronicity of the infection (Bowler and Davies,
1999; Von Eiff et al., 2002).
It must be considered that the present study is a prospective
study but with highly significant results. A more comprehensive
multi-centric study covering a diversity of population along with
previous hospitalization details and prior antibiotic exposure
is warranted to cover a wide array of microbial range. This
information will form a substantive baseline data to elucidate
the causes of high prevalence of non-healing ulcers amongst the
Indian population.
CONCLUSIONS
This study demonstrates the existence of a diversity of
organisms in DFUs. The emerging dominance of Gram-
negative aerobes replacing Gram-positive bacteria in
infected diabetic foot wounds may impose a serious health
burden in healing of ulcers. Therefore, antimicrobial
prescribed should be broadened covering both Gram-
negative and Gram-positive pathogens to improve the
healing status in diabetic foot. Antimicrobial prescribed
should also target multidrug-resistant strains which are a
compounding trouble in treatment of diabetic foot infection
and associated complications. In addition, a proper clinical
analysis, including the presence of neuropathy and vascular
disease, history of ulcerations should be routinely done in
diabetics.
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